Stay updated on Idasanutlin Combo in AML: Clinical Trial
Sign up to get notified when there's something new on the Idasanutlin Combo in AML: Clinical Trial page.

Latest updates to the Idasanutlin Combo in AML: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 has been added. The funding-status notice and Revision: v3.4.1 have been removed.SummaryDifference0.2%

- Check21 days agoChange DetectedA government funding status notice was added and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedGlossary display has been added to the page. Metadata labels have been updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with capitalization adjusted, and the site revision is now listed as v3.4.0.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedThe Locations section was expanded to include new study sites in New York, Pennsylvania, Texas, Australian Capital Territory, New South Wales, South Australia, Victoria, Ontario, Campania, Emilia-Romagna, Friuli Venezia Giulia, Lazio, Liguria, Lombardy, Piedmont, and Tuscany. Revision: v3.3.3.SummaryDifference1.0%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. This is a minor, non-functional update that does not alter the study details or how users interact with the page.SummaryDifference0.0%

Stay in the know with updates to Idasanutlin Combo in AML: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo in AML: Clinical Trial page.